Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...
The Mayfield High School girls’ basketball team is asking the community’s help in raising money for those battling cancer.
Incyte Corporation is rated Strong Buy with recent execution driving a 56% stock rally and robust revenue growth. Learn more ...
News-Medical.Net on MSN
New markers improve detection of aggressive breast cancer cells in the blood
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.
News-Medical.Net on MSN
Cancer mortality drops 34% as treatments and early detection improve
The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...
Findings seen in patients with newly diagnosed clinical stage I to II triple-negative or HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback